154 related articles for article (PubMed ID: 8287315)
1. Decrease of serum calcium concentration and lost influence of calcium on parathyroid hormone release in a patient with primary hyperparathyroidism after treatment with diphosphonates.
Kotzmann H; Bernecker P; Svoboda T; Niederle B; Luger A
Calcif Tissue Int; 1993 Nov; 53(5):301-3. PubMed ID: 8287315
[TBL] [Abstract][Full Text] [Related]
2. [Disodium pamidronate (APD) in therapy of hypercalcemia in primary hyperparathyroidism].
Kotzmann H; Svoboda T; Bernecker P; Clodi M; Woloszczuk W; Niederle B; Waldhäusl W; Luger A
Wien Klin Wochenschr; 1994; 106(13):422-5. PubMed ID: 8091766
[TBL] [Abstract][Full Text] [Related]
3. The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism.
Malberti F; Farina M; Imbasciati E
Nephrol Dial Transplant; 1999 Oct; 14(10):2398-406. PubMed ID: 10528664
[TBL] [Abstract][Full Text] [Related]
4. Biochemical effects from treatment with bisphosphonate and surgery in patients with primary hyperparathyroidism.
Jansson S; Morgan E
World J Surg; 2004 Dec; 28(12):1293-7. PubMed ID: 15517486
[TBL] [Abstract][Full Text] [Related]
5. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
[TBL] [Abstract][Full Text] [Related]
6. [The efficacy and safety of intravenous bisphosphonates in the treatment of primary hyperparathyroidism complicated by hypercalcemia crisis].
Han GY; Wang O; Xing XP; Meng XW; Lian XL; Guan H; Ye W; Xia WB; Li M; Jiang Y; Hu YY; Liu HC; Cui QC
Zhonghua Nei Ke Za Zhi; 2009 Sep; 48(9):729-33. PubMed ID: 20079207
[TBL] [Abstract][Full Text] [Related]
7. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
Jansson S; Tisell LE; Lindstedt G; Lundberg PA
Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
[TBL] [Abstract][Full Text] [Related]
8. Acute effect of pamidronate on PTH secretion in postmenopausal hemodialysis patients with secondary hyperparathyroidism.
Lu KC; Yeung LK; Lin SH; Lin YF; Chu P
Am J Kidney Dis; 2003 Dec; 42(6):1221-7. PubMed ID: 14655194
[TBL] [Abstract][Full Text] [Related]
9. Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism.
Tal A; Graves L
South Med J; 1996 Jun; 89(6):637-40. PubMed ID: 8638211
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of parathyroid operation on serum calcium and parathyroid hormone values in sporadic primary hyperparathyroidism.
Lundgren E; Rastad J; Ridefelt P; Juhlin C; Akerström G; Ljunghall S
Surgery; 1992 Dec; 112(6):1123-9. PubMed ID: 1455314
[TBL] [Abstract][Full Text] [Related]
11. Intact parathyroid hormone in primary hyperparathyroidism.
Flentje D; Schmidt-Gayk H; Fischer S; Stern J; Blind E; Buhr H; Herfarth C
Br J Surg; 1990 Feb; 77(2):168-72. PubMed ID: 2317677
[TBL] [Abstract][Full Text] [Related]
12. Pamidronate administration improves the secondary hyperparathyroidism due to "Bone Hunger Syndrome" in a patient with osteoblastic metastases from prostate cancer.
Berruti A; Sperone P; Fasolis G; Torta M; Fontana D; Dogliotti L; Angeli A
Prostate; 1997 Dec; 33(4):252-5. PubMed ID: 9397197
[TBL] [Abstract][Full Text] [Related]
13. Suppressibility of serum levels of PTH by calcium in the immediate postoperative period after surgery for primary hyperparathyroidism.
Bergenfelz A; Ahrén B
World J Surg; 1993; 17(6):806-10. PubMed ID: 8109123
[TBL] [Abstract][Full Text] [Related]
14. Functional recovery of the parathyroid glands after surgery for primary hyperparathyroidism.
Bergenfelz A; Valdermarsson S; Ahrén B
Surgery; 1994 Nov; 116(5):827-36. PubMed ID: 7940185
[TBL] [Abstract][Full Text] [Related]
15. Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate.
Shane E; Jacobs TP; Siris ES; Steinberg SF; Stoddart K; Canfield RE; Bilezikian JP
Am J Med; 1982 Jun; 72(6):939-44. PubMed ID: 6211978
[TBL] [Abstract][Full Text] [Related]
16. Hyperparathyroidism due to eutopic PTH secretion from an ectopic intrathymic parathyroid cyst.
Hoi WH; Leow MK; Sule A; Lee HY; Mmed TA; Tay JC
Ann Thorac Cardiovasc Surg; 2011; 17(5):511-3. PubMed ID: 21881376
[TBL] [Abstract][Full Text] [Related]
17. Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism.
Shane E; Baquiran DC; Bilezikian JP
Ann Intern Med; 1981 Jul; 95(1):23-7. PubMed ID: 6264825
[TBL] [Abstract][Full Text] [Related]
18. Effects of the antihypercalcemic drugs gallium nitrate and pamidronate on hormone release of pathologic human parathyroid cells.
Ridefelt P; Gylfe E; Akerström G; Rastad J
Surgery; 1995 Jan; 117(1):56-61. PubMed ID: 7809837
[TBL] [Abstract][Full Text] [Related]
19. Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment.
Adami S; Mian M; Bertoldo F; Rossini M; Jayawerra P; O'Riordan JL; Lo Cascio V
Clin Endocrinol (Oxf); 1990 Sep; 33(3):391-7. PubMed ID: 2147599
[TBL] [Abstract][Full Text] [Related]
20. Aminopropylidine diphosphonate (APD) in mild primary hyperparathyroidism: effect on clinical status.
Schmidli RS; Wilson I; Espiner EA; Richards AM; Donald RA
Clin Endocrinol (Oxf); 1990 Mar; 32(3):293-300. PubMed ID: 2188763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
